MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer. - Wikidata - awgldk - TriplyDB

MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.

MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.

http://www.wikidata.org/entity/Q35795361

about

Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound Healing MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis microRNA regulation of Wnt signaling pathways in development and disease MicroRNA Regulation of Endothelial Junction Proteins and Clinical Consequence The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.The regulation and function of microRNAs in kidney diseases.MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.MicroRNAs as therapeutic targets and their potential applications in cancer therapy.Epigenetic alterations involved in cancer stem cell reprogramming.Oncogenic Wnt/β-catenin signalling pathways in the cancer-resistant epididymis have implications for cancer research.miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.Nucleic acid-based tissue biomarkers of urologic malignancies.MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).Regulation of breast cancer stem cell features.MicroRNA-320a downregulation mediates human liver cancer cell proliferation through the Wnt/β-catenin signaling pathway.DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.MicroRNAs in clear cell renal cell carcinoma: biological functions and applications.MicroRNA 497 modulates interleukin 1 signalling via the MAPK/ERK pathway.

P2860

Q26752925-20DCB6C8-53B2-404C-A42A-6BA340E0034A Q26771827-71A185E7-C45A-48BA-92B7-7B2AB9432774 Q26785371-01FB4527-6DB2-455C-AB81-20633AA29694 Q27011654-8DEDA704-F028-44C0-88EF-512089D77E3D Q28074155-B2BD39E4-EE73-4DC4-A934-FD9D85218FFA Q28076568-A4E1C5E5-AF03-47B5-B990-7B6895500B95 Q28273449-D815886B-3695-4C92-8EF4-417582E47B7C Q33694120-677D58F8-F590-4E46-8DBD-8A6B9306071D Q33740486-084B7A7B-30EB-455B-B4E0-A5AEC5F68D96 Q34391443-6D41D8CD-CB77-45BE-B14B-6F2D2956C013 Q36250644-B0C42E3F-2104-4BC3-8B8F-79BADBEF11D5 Q36561545-1EFFE905-E868-4DB9-84A5-C822E1A7CCB4 Q36960910-6681CAFB-933A-4572-B6DA-6435D1746410 Q37580183-AE2935BF-B3CF-45E1-BD79-2948D14990E4 Q38018097-DEED33AA-FCFE-491B-A445-551CFB8B704A Q38058972-7D7BF1E9-C24C-4135-B616-73A595BE3A27 Q38060099-79E01DE0-3841-499C-B5EC-8F4636ED19E1 Q38096240-D66BDD9E-D352-4826-98C1-3D620A9670B3 Q38216131-C91E58DE-9F3F-4BCA-8D1D-DA52458934A3 Q38356005-32E6BFA0-E797-4F3B-9DE4-E6DEB5231390 Q38359738-A7E80A78-C693-4D1C-835E-45523845AB62 Q42154227-BC9D5F67-F50A-4E65-9507-EAD1F7AF5291 Q48212199-57261BBE-2373-4C6D-8644-7E210EE75DBE Q51158837-52996E38-5895-497D-B015-2568474F695B Q54475672-D9558BEC-EFC2-45E2-9DCA-6D9F2FCF6321

P2860

MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.

http://www.wikidata.org/entity/Q35795361

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

MicroRNA-1826 directly targets ...... VHL-inactivated renal cancer.

@ast

MicroRNA-1826 directly targets ...... VHL-inactivated renal cancer.

@en

type

label

MicroRNA-1826 directly targets ...... VHL-inactivated renal cancer.

@ast

MicroRNA-1826 directly targets ...... VHL-inactivated renal cancer.

@en

prefLabel

MicroRNA-1826 directly targets ...... VHL-inactivated renal cancer.

@ast

MicroRNA-1826 directly targets ...... VHL-inactivated renal cancer.

@en

P1433

Q35795361-B8ECD6BB-7D41-45CB-B8F6-DAD5E2699D85

P1476

Q35795361-6C423ACB-A7FA-4D7F-A543-FE6B83181F1E

P2093

Q35795361-097A74E9-E214-44EC-8C84-6D5396C722E9

Q35795361-25055AF9-9AD1-47E9-B88E-306DEC9C52A6

Q35795361-379463D7-7E1D-48D3-A9BA-8532690AAEC8

Q35795361-79825E40-FC0F-432A-82C8-C475774B8173

Q35795361-B3A2C44F-89E2-4285-B197-BC7EC1230571

Q35795361-CE31A46B-61E0-428D-93E6-6A14862D5DA1

P2860

Q35795361-04FC12B8-814D-44B0-9DAE-DB978BF6A1DD

Q35795361-2CAF12CF-DF23-4117-AF50-F1C77C5EB768

Q35795361-34A071F6-92C3-49BB-9D64-615AEA7A1087

Q35795361-41A941E7-66F1-47E0-A34F-BFE5E6E2E974

Q35795361-46431251-6624-4EF3-8EF3-09EA65995CC4

Q35795361-4A09F38F-5E26-4162-8ACD-EA00401831EC

Q35795361-4F035D09-C9D2-4679-80AB-34D2ED75016C

Q35795361-5E15FC23-558F-4FD4-AEE3-373D627A8EF3

Q35795361-5E3BA755-D03C-47C0-8E77-6B959C3F8BE9

Q35795361-64165A93-89B8-477F-8594-E0510672F738

P304

Q35795361-26BC6435-49AA-4BD6-A06D-B811A5D8BAED

P31

Q35795361-192731CE-22AB-424B-9E9D-23A679FCF34D

P356

Q35795361-5AF48BD6-C113-4C48-87DC-B4BCD37CCB4A

P407

Q35795361-087BD950-75E6-4E10-BD6F-979325627E24

P433

Q35795361-6BFF790B-3A2C-4AB5-B51C-31264547DA28

P478

Q35795361-AB15394D-7D6A-4B0A-BE2E-807EB0200C2F

P577

Q35795361-F31309E3-FEE0-4F07-B4EB-C52CF7DB7699

P5875

Q35795361-E84C2FC7-0C2B-446C-823F-AA8E016A665A

P698

Q35795361-A8857BBB-72F1-4FD5-AD67-FD08D665972D

P921

Q35795361-8F3797B9-2415-4170-B09D-E8743BB81D28

P932

Q35795361-547FB623-EE52-4F92-9E6F-F74145DA11D8

P356

P1433

P1476

MicroRNA-1826 directly targets ...... VHL-inactivated renal cancer.

@en

P2093

Hiroshi Hirata

http://www.w3.org/2001/XMLSchema#string

Koichi Nakajima

http://www.w3.org/2001/XMLSchema#string

Koji Ueno

http://www.w3.org/2001/XMLSchema#string

Nobuhisa Ishii

http://www.w3.org/2001/XMLSchema#string

Rajvir Dahiya

http://www.w3.org/2001/XMLSchema#string

Yuji Hinoda

http://www.w3.org/2001/XMLSchema#string

P2860

Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: its implications to therapy

Cancer statistics, 2008

miRDB: a microRNA target prediction and functional annotation database with a wiki interface

Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma.

Molecular diagnosis and therapy of kidney cancer.

Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery

MicroRNAs as potential cancer therapeutics.

The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells

Targeting the ERK signaling pathway in cancer therapy.

Mining the Wnt pathway for cancer therapeutics.

P304

501-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGR302

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51899104

http://www.w3.org/2001/XMLSchema#string

P698

22180573

http://www.w3.org/2001/XMLSchema#string

P921

P932

3291860

http://www.w3.org/2001/XMLSchema#string